JOIN THE BATTLE. Beat Rare Cancers.
The Glass is Half Full is riding for Alicia Eppler who is battling a rare cancer called GIST. She has survived for the past 7 years because of three successful operations, overall good health, Gleevec and now a clinical trial (DCC-2618). Gleevec and DCC-2618 are targeted oral therapies which would not have been created without funding for rare cancer research. Alicia is indebted to her doctors at MSKCC: Gary Schwartz, Ronald DeMatteo and William Tap and his research team. She has had a quality of life and has hope. Her family and her friends are her rock and support system. She feels blessed and considers herself very lucky!
WELCOME TO OUR TEAM'S PAGE!
We are riding and raising money for Cycle for Survival, the movement to beat rare cancers. Will you help us surpass our fundraising goal?
Why this matters to us:
50% of People with Cancer Have a Rare Cancer
When combined, about half of all patients fighting cancer are fighting a rare cancer. These are cancers we know — such as leukemia, lymphoma, thyroid, ovarian, brain, pancreatic, and all pediatric cancers — yet research is largely underfunded.
100% Goes to Lifesaving Research Led by MSK
Every dollar you give will advance innovative studies and clinical trials led by Memorial Sloan Kettering Cancer Center (MSK). Discoveries made by MSK revolutionize how cancer is diagnosed and treated, helping patients across the country and around the world.
6 Months for Fast Impact
Not only does every dollar go to research, your gift will be in the hands of doctors and researchers within six months of the events. As a donor, you will learn about the projects supported and the breakthroughs made.
Join our team or make a donation today. Your efforts will fight cancer and make a real impact for people who have few, if any, treatment options.
Thank you in advance for your support!
JOIN THE BATTLE.
If you think this page contains objectionable content, please inform the system administrator.